Publications by authors named "David P Turicek"

Claim this Profile
A
A microenvironment-driven HLA-II-associated insulin neoantigen elicits persistent memory T cell activation in diabetes.
Neetu Srivastava, Anthony N Vomund, Rongzhen Yu, Orion J Peterson, Yuqing Yang, David P Turicek

Nat Immunol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A microenvironment-driven, HLA-II-associated insulin neoantigen elicits persistent memory T cell activation in diabetes.
Neetu Srivastava, Anthony N Vomund, Rongzhen Yu, Orion J Peterson, Yuqing Yang, David P Turicek

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding autoimmunity: HLA-DQβ and type 1 diabetes.
David P Turicek, Xiaoxiao Wan

J Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma.
Monica M Cho, Longzhen Song, Aicha E Quamine, Fernanda Szewc, Lei Shi, David P Turicek

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epigenetic trajectory of type 1 regulatory T cells.
David P Turicek, Xiaoxiao Wan

Elife· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for standardization of cytokine profiling in CAR T cell therapy.
D Nathan Biery, David P Turicek, Caroline Diorio, Brett A Schroeder, Nirali N Shah

Mol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma.
Monica M Cho, Longzhen Song, Aicha E Quamine, Fernanda Szewc, Lei Shi, David P Turicek

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expression.
Sean P Rinella, Haley C Bell, Nicholas J Hess, Nguyet-Minh Hoang, Thao Trang Nguyen, David P Turicek

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-cell detection scoping review: an essential biomarker in critical need of standardization.
David P Turicek, Victoria M Giordani, Josquin Moraly, Naomi Taylor, Nirali N Shah

J Immunother Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology.
Nicholas J Hess, David P Turicek, Jeremiah Riendeau, Sean J McIlwain, Emmanuel Contreras Guzman

Sci Adv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration.
Kirsti L Walker, Sean P Rinella, Nicholas J Hess, David P Turicek, Sabrina A Kabakov

Leuk Lymphoma· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis